Related Experiment Video
Updated: May 10, 2025

08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
2.1K
Common data elements for food allergy clinical trials: an overview.
Shruti Sehgal1, Justin Starren2, Kyle Cattin1
1Center for Food Allergy and Asthma Research; Northwestern University Feinberg School of Medicine; Chicago, Illinois.
Current Opinion in Allergy and Clinical Immunology
|April 22, 2025
Summary
Developing standardized common data elements (CDEs) for food allergy research is crucial. Implementing CDEs will improve data consistency, interoperability, and accelerate clinical trials for this growing public health issue.
Area of Science:
- Immunology
- Public Health
- Clinical Research Informatics
Background:
- Food allergy affects 8% of children and 11% of adults in the US, representing a significant public health concern.
- Current food allergy research is hindered by a lack of standardized data fields and common data elements (CDEs).
Purpose of the Study:
- To highlight the critical need for developing CDEs specifically for food allergy research.
- To discuss the anticipated positive impact of implementing CDEs in food allergy studies.
- To describe the fundamental principles of CDEs.
Main Methods:
- Review of existing literature and initiatives supporting data standardization in clinical research.
- Analysis of the impact of data standardization on research quality and efficiency.
- Description of the core components and benefits of CDEs.
Main Results:
- Standardization of data definitions and consistent data collection are essential for robust clinical research.
- Collaboration among NIH centers is actively supporting the development of CDEs, promoting FAIR data principles.
Conclusions:
- The rising burden of food allergies necessitates a standardized approach to documenting clinical research data.
- Nationally and globally, the development and adoption of food allergy CDEs are vital for understanding and mitigating this immune-mediated disease.
- CDEs will enhance data consistency, interoperability, and expedite high-quality future food allergy clinical trials.
Related Concept Videos
Allergic Reactions
27.1K
Overview
27.1K
Clinical Trials: Overview
2.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.4K
Allergic Drug Reactions
786
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
786
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Cross-reactivity
30.9K
Overview
30.9K
Antibody Structure
57.5K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
57.5K

